PRF Technologies (PRFX) Retained Earnings (2019 - 2025)
PRF Technologies' (PRFX) quarterly Retained Earnings came in at $69.8 million in Q4 2025, up 19.83% YoY from $58.3 million in Q4 2024, and up 218.83% on a QoQ basis from -$58.8 million in Q2 2025.
PRF Technologies (PRFX) Retained Earnings (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Retained Earnings data on file, last reported at $69.8 million in Q4 2025.
- Quarterly Retained Earnings rose 19.83% year-over-year to $69.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $69.8 million (up 19.83% YoY) and the FY2025 annual result came in at $69.8 million, up 19.83% from the prior year.
- Retained Earnings improved to $69.8 million in Q4 2025, from -$58.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $69.8 million in Q4 2025 to a low of -$58.8 million in Q2 2025.
- A 5-year average of -$11.8 million and a median of -$25.4 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings sank 103.32% — and 2024, when it jumped 4135.66%.
- Tracing PRFX's Retained Earnings over 5 years: stood at $41.7 million in 2021, then climbed by 4.15% to $43.4 million in 2022, then slumped by 103.32% to -$1.4 million in 2023, then jumped by 4135.66% to $58.3 million in 2024, then gained by 19.83% to $69.8 million in 2025.
- The last three Retained Earnings figures came in at $69.8 million (Q4 2025), -$58.8 million (Q2 2025), and $58.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 69.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.83 Mn |
| Jun 30, 2025 | -58.77 Mn |
| Dec 31, 2024 | 58.28 Mn |
| Jun 30, 2024 | -54.68 Mn |
| Mar 31, 2024 | -47.37 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | -36.97 Mn |
| Jun 30, 2023 | -37.01 Mn |
| Mar 31, 2023 | -34.83 Mn |
| Dec 31, 2022 | 43.45 Mn |
| Sep 30, 2022 | -29.35 Mn |
| Jun 30, 2022 | -27.24 Mn |
| Mar 31, 2022 | -25.42 Mn |
| Dec 31, 2021 | 41.72 Mn |
| Sep 30, 2021 | -21.99 Mn |
| Jun 30, 2021 | -20.22 Mn |
| Mar 31, 2021 | -18.52 Mn |
| Dec 31, 2020 | 33.02 Mn |
| Jun 30, 2020 | -14.39 Mn |
| Dec 31, 2019 | -12.43 Mn |